telehealth glp-1 crackdown news today The FDA is cracking down on ‘misleading’ compounded GLP-1s from companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, Telehealth Booms as Demand for
Description
Value Based Care Group
Your body depends on glucose for energy
Symptoms are surprisingly easy to manage once you know how!
Please note: GLP-ONE Support Multivitamin Nutrient Renewal does not meet ASMBS guidelines, but it can be used pre-operatively during the liver reduction diet to support nutritional status before surgery
Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial
